Skip to content

Organon OGN Intangible Purchases

Intangible Purchases at other companies

Biogen logo
BiogenBIIB
$0-100%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$7.85M+86.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$1.49M+128%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$5M-66.7%
HRO
HarrowHROW
$9K-78.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$5.25M-69.8%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's intangible purchases?
Organon (OGN) reported intangible purchases of $0 in Q1 2026.
How has Organon's intangible purchases changed year-over-year?
Organon's intangible purchases decreased by 100.0% year-over-year, from $55M to $0.
What is the long-term trend for Organon's intangible purchases?
Over 2 years (2022 to 2024), Organon's intangible purchases has grown at a -8.0% compound annual growth rate (CAGR), from $124M to $105M.
What does intangible purchases mean?
Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.